Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease

• Conditions: Systemic Inflammation (hsCRP)

• Registration Number: NCT06655493
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease) with/without kidney disease.
...

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2024-10-21
• Study First Submitted QC: 2024-10-21
• Study First Posted: 2024-10-23
• Study Start: 2024-11-30
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-13
• Last Update Posted: 2024-12-16
• Primary Completion: 2025-09-30
• Study Completion: 2025-09-30

Recruitment & Eligibility

• Status: ENROLLING_BY_INVITATION
• Sex: All
• Target Recruitment: 756

Inclusion Criteria

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, age above or equal to 18 years at the time of signing informed consent.
3. Diagnosed with ASCVD+CKD and/or HF (pEF or mrEF)

Read More

Exclusion Criteria

1. Previous participation in this study. Participation is defined as having given informed consent in this study.
2. Current participation (i.e., signed informed consent) in any other interventional clinical study.
3. Any hospitalization or unplanned visit within the last 60 days (including exacerbation of chronic disease with hospitalization).
4. Clinical evidence, or suspicion of, active infection within the last 60 days.
5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
High Sensitivity C-Reactive Protein (hsCRP) ≥2 mg/L	At Visit (day 0)	Count of patients

Trial Locations

Locations (20)

Almoosa Specialist Hospital; 🇸🇦 Al Ahsa, Saudi Arabia

National Guard- Alahsa; 🇸🇦 Al Ahsa, Saudi Arabia

King Fahad Armed Forces, Jeddah; 🇸🇦 Jeddah, Saudi Arabia

King Faisal Specialist Hospital & Research Centre, Jeddah; 🇸🇦 Jeddah, Saudi Arabia

National Guard Hospital_Riyadh; 🇸🇦 Riyadh, Saudi Arabia

Dr. Sulaiman Al Habib Medical Group- Olaya; 🇸🇦 Riyadh, Saudi Arabia

King Khaled University Hospital,King Saud Univ. Med. City; 🇸🇦 Riyadh, Saudi Arabia

SMC, Riyadh; 🇸🇦 Riyadh, Saudi Arabia

King Fahad Medical City; 🇸🇦 Riyadh, Saudi Arabia

King Salman North Western Armed Force Hospital (NWAFH); 🇸🇦 Tabuk, Saudi Arabia

Cleveland Clinic Abu Dhabi; 🇦🇪 Abu Dhabhi, United Arab Emirates

Tawam Hospital (SEHA); 🇦🇪 Abu Dhabhi, United Arab Emirates

Mediclinic Abu Dhabi; 🇦🇪 Abu Dhabhi, United Arab Emirates

Imperial college, Abu Dhabi; 🇦🇪 Abu Dhabhi, United Arab Emirates

Rashid Hospital; 🇦🇪 Dubai, United Arab Emirates

Tadwai hospital; 🇦🇪 Dubai, United Arab Emirates

Dubai Hospital; 🇦🇪 Dubai, United Arab Emirates

Fujairah Hospital; 🇦🇪 Fujairah, United Arab Emirates

Sheikh Khalifa Hospital Fujairah; 🇦🇪 Fujairah, United Arab Emirates

Al Qassimi Hospital, Sharjah; 🇦🇪 Sharjah, United Arab Emirates